Search

Your search keyword '"Krueger CG"' showing total 59 results

Search Constraints

Start Over You searched for: Author "Krueger CG" Remove constraint Author: "Krueger CG"
59 results on '"Krueger CG"'

Search Results

1. Differences in P-Type and Type 1 Uropathogenic Escherichia coli Urinary Anti-Adhesion Activity of Cranberry Fruit Juice Dry Extract Product and D-Mannose Dietary Supplement.

2. Improved in vitro Hemagglutination Assays Utilizing P-Type and Type 1 Uropathogenic Escherichia coli to Evaluate Bacterial Anti-Adhesion Activity of Cranberry Products.

3. Cranberry proanthocyanidins composite electrospun nanofibers as a potential alternative for bacterial entrapment applications.

4. Synthesis of Fluorescent Proanthocyanidin-Cinnamaldehydes Pyrylium Products for Microscopic Detection of Interactions with Extra-Intestinal Pathogenic Escherichia coli .

5. Inter-Laboratory Validation of 4-(Dimethylamino) Cinnamaldehyde (DMAC) Assay Using Cranberry Proanthocyanidin Standard for Quantification of Soluble Proanthocyanidins in Cranberry Foods and Dietary Supplements, First Action Official MethodSM: 2019.06.

6. Identification of A-Type Proanthocyanidins in Cranberry-Based Foods and Dietary Supplements by Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry, First Action Method: 2019.05.

7. Classification of proanthocyanidin profiles using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) spectra data combined with multivariate analysis.

8. Antimicrobial proanthocyanidin-chitosan composite nanoparticles loaded with gentamicin.

9. Effect of birdsfoot trefoil cultivars on exsheathment of Haemonchus contortus in fistulated sheep.

10. Characterization of proanthocyanidin-chitosan interactions in the formulation of composite nanoparticles using surface plasmon resonance.

11. Development of a Cranberry Standard for Quantification of Insoluble Cranberry ( Vaccinium macrocarpon Ait.) Proanthocyanidins.

12. Composition of Anthocyanins and Proanthocyanidins in Three Tropical Vaccinium Species from Costa Rica.

13. Proanthocyanidin-chitosan composite nanoparticles prevent bacterial invasion and colonization of gut epithelial cells by extra-intestinal pathogenic Escherichia coli.

14. In vitro screening of 51 birdsfoot trefoil (Lotus corniculatus L.; Fabaceae) strains for anti-parasitic effects against Haemonchus contortus.

15. Cranberry proanthocyanidin-chitosan hybrid nanoparticles as a potential inhibitor of extra-intestinal pathogenic Escherichia coli invasion of gut epithelial cells.

16. Anthelmintic efficacy of cranberry vine extracts on ovine Haemonchus contortus.

17. Effect of Sweetened Dried Cranberry Consumption on Urinary Proteome and Fecal Microbiome in Healthy Human Subjects.

18. An extract from date palm fruit (Phoenix dactylifera) acts as a co-agonist ligand for the nuclear receptor FXR and differentially modulates FXR target-gene expression in vitro.

19. Effect of Caloric Restriction on Metabolic Dysfunction of Young Rapacz Familial Hypercholesterolemic Swine ( Sus scrofa ).

20. Cranberry Proanthocyanidins - Protein complexes for macrophage activation.

21. Non-covalent pomegranate (Punica granatum) hydrolyzable tannin-protein complexes modulate antigen uptake, processing and presentation by a T-cell hybridoma line co-cultured with murine peritoneal macrophages.

22. Impact of Cranberries on Gut Microbiota and Cardiometabolic Health: Proceedings of the Cranberry Health Research Conference 2015.

23. Development of Aortic Valve Disease in Familial Hypercholesterolemic Swine: Implications for Elucidating Disease Etiology.

24. Methods to determine effects of cranberry proanthocyanidins on extraintestinal infections: Relevance for urinary tract health.

25. Measurements of wall shear stress and aortic pulse wave velocity in swine with familial hypercholesterolemia.

26. Fluorescent labeling of cranberry proanthocyanidins with 5-([4,6-dichlorotriazin-2-yl]amino)fluorescein (DTAF).

27. Gene Expression Profiling of Valvular Interstitial Cells in Rapacz Familial Hypercholesterolemic Swine.

28. Bioavailability, bioactivity and impact on health of dietary flavonoids and related compounds: an update.

29. Supercritical fluid extraction (SFE) of cranberries does not extract oligomeric proanthocyanidins (PAC) but does alter the chromatography and bioactivity of PAC fractions extracted from SFE residues.

30. Imaging RAGE expression in atherosclerotic plaques in hyperlipidemic pigs.

31. Ratio of "A-type" to "B-type" proanthocyanidin interflavan bonds affects extra-intestinal pathogenic Escherichia coli invasion of gut epithelial cells.

32. Experimental evaluation of efficacy and healing response of everolimus-eluting stents in the familial hypercholesterolemic swine model: a comparative study of bioabsorbable versus durable polymer stent platforms.

33. Development and phytochemical characterization of high polyphenol red lettuce with anti-diabetic properties.

34. Cranberry proanthocyanidins improve intestinal sIgA during elemental enteral nutrition.

35. Food-compatible method for the efficient extraction and stabilization of cranberry pomace polyphenols.

36. Concord grape pomace polyphenols complexed to soy protein isolate are stable and hypoglycemic in diabetic mice.

37. Consumption of sweetened, dried cranberries may reduce urinary tract infection incidence in susceptible women--a modified observational study.

38. Parenteral nutrition increases susceptibility of ileum to invasion by E coli.

39. Gene expression differences during the heterogeneous progression of peripheral atherosclerosis in familial hypercholesterolemic swine.

40. Quantifying and characterizing proanthocyanidins in cranberries in relation to urinary tract health.

41. Cranberry proanthocyanidins improve the gut mucous layer morphology and function in mice receiving elemental enteral nutrition.

42. Deconvolution of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry isotope patterns to determine ratios of A-type to B-type interflavan bonds in cranberry proanthocyanidins.

43. Evaluation of efficacy and dose response of different paclitaxel-coated balloon formulations in a novel swine model of iliofemoral in-stent restenosis.

44. Displacement and strain estimation for evaluation of arterial wall stiffness using a familial hypercholesterolemia swine model of atherosclerosis.

45. Differential effects of grape ( Vitis vinifera ) skin polyphenolics on human platelet aggregation and low-density lipoprotein oxidation.

46. Comparison of isolated cranberry (Vaccinium macrocarpon Ait.) proanthocyanidins to catechin and procyanidins A2 and B2 for use as standards in the 4-(dimethylamino)cinnamaldehyde assay.

47. Vascular response to zotarolimus-coated balloons in injured superficial femoral arteries of the familial hypercholesterolemic Swine.

48. Gene expression differences in healthy brachial and femoral arteries of Rapacz familial hypercholesterolemic swine.

49. Coronary bare metal stent implantation in homozygous LDL receptor deficient swine induces a neointimal formation pattern similar to humans.

50. Contrast-enhanced ultrasound for imaging vasa vasorum: comparison with histopathology in a swine model of atherosclerosis.

Catalog

Books, media, physical & digital resources